Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor Simard

Showing results (91-100 of 159) with videos related to

Pageof 16
Sort By:
CJC Open|October 29, 2021
De-escalation of P2Y12 Inhibitor Use After Percutaneous Coronary Intervention and Acute Coronary SyndromesQuinton Barry, Angel Fu, Rene Boudreau, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|January 24, 2025
Utility of Noninvasive Testing Before Invasive Coronary Angiography in the Assessment for RevascularizationSimon Parlow, Richard G Jung, Pietro Di Santo, et al.
Journal of Cardiology|June 21, 2022
No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trialGraeme Prosperi-Porta, Pouya Motazedian, Pietro Di Santo, et al.
Frontiers in Cardiovascular Medicine|September 25, 2023
Dipyridamole and vascular healing following stent implantationTrevor Simard, Richard Jung, Pietro Di Santo, et al.
Annals of Internal Medicine|August 6, 2019
Comparative Accuracy of Focused Cardiac Ultrasonography and Clinical Examination for Left Ventricular Dysfunction and Valvular Heart Disease: A Systematic Review and Meta-analysisJeffrey A Marbach, Aws Almufleh, Pietro Di Santo, et al.
Journal of the American Heart Association|March 9, 2022
Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI TrialJeffrey A Marbach, Pietro Di Santo, Navin K Kapur, et al.
Plos One|March 22, 2014
A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD studyBenjamin Hibbert, Ronnen Maze, Ali Pourdjabbar, et al.
The Canadian Journal of Cardiology|April 17, 2022
Significant Valvular Dysfunction and Outcomes in Cardiogenic Shock: Insights From the Randomized DOREMI TrialSimon Parlow, Willy Weng, Pietro Di Santo, et al.
Journal of the American College of Cardiology|June 15, 2013
Serum heat shock protein 27 levels represent a potential therapeutic target for atherosclerosis: observations from a human cohort and treatment of female miceTara A Seibert, Benjamin Hibbert, Yong-Xiang Chen, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|July 17, 2020
Long-term mortality and costs following use of Impella® for mechanical circulatory support: a population-based cohort studyShannon M Fernando, Danial Qureshi, Peter Tanuseputro, et al.
Pageof 16

Showing results (91-100 of 159) with videos related to

Sort By:
Pageof 16
CJC Open|October 29, 2021
De-escalation of P2Y12 Inhibitor Use After Percutaneous Coronary Intervention and Acute Coronary SyndromesQuinton Barry, Angel Fu, Rene Boudreau, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|January 24, 2025
Utility of Noninvasive Testing Before Invasive Coronary Angiography in the Assessment for RevascularizationSimon Parlow, Richard G Jung, Pietro Di Santo, et al.
Journal of Cardiology|June 21, 2022
No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trialGraeme Prosperi-Porta, Pouya Motazedian, Pietro Di Santo, et al.
Frontiers in Cardiovascular Medicine|September 25, 2023
Dipyridamole and vascular healing following stent implantationTrevor Simard, Richard Jung, Pietro Di Santo, et al.
Annals of Internal Medicine|August 6, 2019
Comparative Accuracy of Focused Cardiac Ultrasonography and Clinical Examination for Left Ventricular Dysfunction and Valvular Heart Disease: A Systematic Review and Meta-analysisJeffrey A Marbach, Aws Almufleh, Pietro Di Santo, et al.
Journal of the American Heart Association|March 9, 2022
Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI TrialJeffrey A Marbach, Pietro Di Santo, Navin K Kapur, et al.
Plos One|March 22, 2014
A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD studyBenjamin Hibbert, Ronnen Maze, Ali Pourdjabbar, et al.
The Canadian Journal of Cardiology|April 17, 2022
Significant Valvular Dysfunction and Outcomes in Cardiogenic Shock: Insights From the Randomized DOREMI TrialSimon Parlow, Willy Weng, Pietro Di Santo, et al.
Journal of the American College of Cardiology|June 15, 2013
Serum heat shock protein 27 levels represent a potential therapeutic target for atherosclerosis: observations from a human cohort and treatment of female miceTara A Seibert, Benjamin Hibbert, Yong-Xiang Chen, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|July 17, 2020
Long-term mortality and costs following use of Impella® for mechanical circulatory support: a population-based cohort studyShannon M Fernando, Danial Qureshi, Peter Tanuseputro, et al.
Pageof 16